Celltrion
4 recent articles
- biotech· 전자신문 IT (ETNews)· 7/19/2026★ 7.0
Celltrion Closes In on Samsung BioLogics... Could It Top the Domestic Pharma and Bio Industry for the First Time?
- biotech· 디지털투데이 (DigitalToday)· 6/18/2026★ 7.0
Celltrion's Rashima Subcutaneous (CT-P13 SC) European Phase 3 Trial Part 1 Approval Expired
- biotech· 디지털투데이 (DigitalToday)· 6/18/2026★ 8.0
Celltrion Decides to Expire European Phase 3 Clinical Trial Plan
- biotech· 한국경제 IT (Hankyung)· 6/10/2026★ 8.0
[핫 컴퍼니]마이크로바이옴 국내 첫 기술이전 성공한 고바이오랩 “'미생물 약물공장' mDDS 도전”